TDAM USA’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $9.14M | Buy |
125,911
+4,930
| +4% | +$340K | 0.57% | 56 |
|
|
2021
Q3 | $8.45M | Buy |
120,981
+699
| +0.6% | +$49.1K | 0.56% | 58 |
|
|
2021
Q2 | $8.21M | Buy |
120,282
+106,134
| +750% | +$7.09M | 0.51% | 64 |
|
|
2021
Q1 | $914K | Buy |
14,148
+22
| +0.2% | +$1.42K | 0.06% | 173 |
|
|
2020
Q4 | $823K | Sell |
14,126
-35
| -0.2% | -$2.11K | 0.05% | 173 |
|
|
2020
Q3 | $895K | Buy |
14,161
+632
| +5% | +$43.8K | 0.06% | 162 |
|
|
2020
Q2 | $1.01M | Buy |
13,529
+966
| +8% | +$74K | 0.07% | 160 |
|
|
2020
Q1 | $939K | Buy |
12,563
+399
| +3% | +$27.6K | 0.08% | 161 |
|
|
2019
Q4 | $790K | Sell |
12,164
-1,037
| -8% | -$67.5K | 0.05% | 183 |
|
|
2019
Q3 | $837K | Buy |
13,201
+675
| +5% | +$44.1K | 0.06% | 181 |
|
|
2019
Q2 | $846K | Sell |
12,526
-10,445
| -45% | -$687K | 0.06% | 177 |
|
|
2019
Q1 | $1.49M | Sell |
22,971
-1,273
| -5% | -$84.6K | 0.11% | 140 |
|
|
2018
Q4 | $1.52M | Sell |
24,244
-5,910
| -20% | -$413K | 0.11% | 137 |
|
|
2018
Q3 | $2.26M | Buy |
30,154
+630
| +2% | +$47.6K | 0.14% | 126 |
|
|
2018
Q2 | $2.09M | Sell |
29,524
-1,111
| -4% | -$78.5K | 0.13% | 127 |
|
|
2018
Q1 | $2.31M | Sell |
30,635
-180
| -0.6% | -$14.3K | 0.14% | 116 |
|
|
2017
Q4 | $2.21M | Sell |
30,815
-1,108
| -3% | -$84.1K | 0.13% | 126 |
|
|
2017
Q3 | $2.59M | Sell |
31,923
-720
| -2% | -$55.1K | 0.15% | 112 |
|
|
2017
Q2 | $2.31M | Sell |
32,643
-4,679
| -13% | -$311K | 0.12% | 129 |
|
|
2017
Q1 | $2.54M | Sell |
37,322
-2,932
| -7% | -$206K | 0.13% | 125 |
|
|
2016
Q4 | $2.88M | Sell |
40,254
-2,881
| -7% | -$214K | 0.15% | 118 |
|
|
2016
Q3 | $3.41M | Sell |
43,135
-111,105
| -72% | -$9.03M | 0.17% | 128 |
|
|
2016
Q2 | $12.9M | Sell |
154,240
-13,022
| -8% | -$1.16M | 0.63% | 51 |
|
|
2016
Q1 | $15.4M | Buy |
167,262
+24,067
| +17% | +$2.17M | 0.75% | 46 |
|
|
2015
Q4 | $14.5M | Buy |
143,195
+4,856
| +4% | +$505K | 0.7% | 48 |
|
|
2015
Q3 | $13.6M | Buy |
138,339
+46,061
| +50% | +$5.12M | 0.69% | 48 |
|
|
2015
Q2 | $10.8M | Buy |
92,278
+34,240
| +59% | +$3.74M | 0.49% | 67 |
|
|
2015
Q1 | $5.7M | Sell |
58,038
-3,858
| -6% | -$392K | 0.23% | 112 |
|
|
2014
Q4 | $5.83M | Sell |
61,896
-8,690
| -12% | -$899K | 0.25% | 110 |
|
|
2014
Q3 | $7.51M | Sell |
70,586
-9,770
| -12% | -$957K | 0.33% | 99 |
|
|
2014
Q2 | $6.66M | Sell |
80,356
-18,112
| -18% | -$1.41M | 0.28% | 109 |
|
|
2014
Q1 | $6.98M | Sell |
98,468
-21,561
| -18% | -$1.69M | 0.3% | 105 |
|
|
2013
Q4 | $9.01M | Sell |
120,029
-141,395
| -54% | -$9.85M | 0.39% | 82 |
|
|
2013
Q3 | $16.4M | Sell |
261,424
-111,668
| -30% | -$6.67M | 0.78% | 45 |
|
|
2013
Q2 | $20.3M | Buy |
+373,092
| New | +$19.4M | 0.93% | 33 |
|
Other funds holding GILD
TDAM USA's GILD Position: Q4 2021 in Review
TDAM USA increased its Gilead Sciences (GILD) stake by 4.1% in Q4 2021, buying an estimated $340K and bringing the position to 125,911 shares worth $9.14M. The position accounts for 0.57% of the portfolio, ranked #56.
TDAM USA first reported a position in GILD in Q2 2013 and has held it in 35 quarters since. The position peaked at $20.3M in Q2 2013. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- TDAM USA held 125,911 shares of Gilead Sciences worth $9.14M as of Q4 2021.
- TDAM USA bought 4,930 Gilead Sciences shares in Q4 2021, an estimated $340K.
- Gilead Sciences made up 0.57% of TDAM USA's portfolio in Q4 2021, its #56 holding.
- TDAM USA first reported a position in Gilead Sciences in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Gilead Sciences position peaked at $20.3M in Q2 2013.
- 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.